Parkinson's disease treatment cost in Poland is primarily determined by the chosen therapeutic approach and disease stage. Diagnostic procedures like a brain MRI with contrast typically range from $200 to $300. Major surgical interventions, such as deep brain stimulation (DBS), run from $30,000 to $45,000. Patients can expect savings of 40-60% compared to the US. Top destinations for care include Warsaw, Krakow, and Rzeszow.
Typical Parkinson's Disease Treatment Costs in Poland
Bookimed Expert Insight: For advanced cases, large university centers provide the most comprehensive surgical value. University Hospital in Krakow serves 455,000 patients annually with excellent technical equipment. Patients focused on neurological rehabilitation should consider specialized private clinics. The Holy Family High Specialty Hospital is highly rated for rehabilitation services. This facility belongs to GVM Care & Research, a major European healthcare group. Their multidisciplinary approach ensures stable long-term management for international patients.
| Poland | Turkey | Austria | |
| Medication treatment for Parkinson's disease | from $1,800 | from $1,000 | from $2,000 |
| Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) | from $12,500 | from $10,000 | from $16,000 |
| Deep brain stimulation (DBS) surgery | from $30,000 | from $23,000 | from $45,000 |
| Stem cell therapy for Parkinson's disease | from $20,000 | from $25,000 | from $35,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Parkinson's disease treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Parkinson's disease treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Parkinson's disease treatment journey.
Written by Kateryna Zamkovska
Primary Parkinson’s treatments in Poland include pharmacological therapy, Deep Brain Stimulation (DBS), and device-aided infusion pumps. Specialist centers in Warsaw and Krakow provide advanced options like MR-guided focused ultrasound (MRgFUS). Early-stage care focuses on levodopa dosing and dopaminergic medications to manage motor symptoms effectively.
Bookimed Expert Insight: University Hospital in Krakow serves a massive volume of 455,000 patients annually. This scale allows for highly specialized multidisciplinary teams that are rare in smaller clinics. Patients seeking complex DBS or device-aided therapies benefit from this concentrated expertise in major medical hubs.
Patient Consensus: Patients note that starting with a movement disorder specialist in larger cities speeds up access to infusion trials. Many suggest tracking medication side effects closely to justify earlier switches to advanced therapies.
Warsaw, Krakow, and Rzeszow are the leading hubs for Parkinson’s care in Poland. These cities host major university hospitals and specialized centers. Facilities like University Hospital in Krakow provide advanced surgical interventions. These include deep brain stimulation (DBS) and MRgFUS for motor symptom management.
Bookimed Expert Insight: While Warsaw is the research hub, Krakow’s University Hospital is a massive clinical powerhouse. It employs over 1,000 doctors across 103 departments. This scale is vital for Parkinson’s because the disease requires multi-specialty coordination. Patients benefit from having neurologists, surgeons, and therapists in one 1,600-bed facility.
Patient Consensus: Patients note that public university hospitals offer the most advanced surgery. Many choose to pay privately to skip the standard 6-month wait times.
Advanced device-aided therapies in Poland are partially reimbursed via the Specialist Therapeutic Programme. Deep Brain Stimulation (DBS) is fully covered for eligible patients. Infusion therapies like Levodopa-Carbidopa receive medication reimbursement. Patients often pay out-of-pocket for delivery pumps or newer lightweight devices.
Bookimed Expert Insight: Poland's high patient volume at centers like University Hospital in Krakow creates significant waiting lists for reimbursed DBS. While 82 clinics operate in Poland, advanced device therapies remain concentrated in major academic hubs. Patients often choose private treatment or travel to nearby Germany for faster access to the latest infusion pump technology.
Patient Consensus: Patients note that public system approval requires meticulous documentation of oral medication failures. Many describe traveling to larger cities or seeking private options because infusion therapies remain rare in regional public hospitals.
Parkinson's patients in Poland face fragmented care characterized by severe regional disparities and limited access to advanced therapies. Specialist expertise is concentrated in major cities like Krakow and Rzeszow. Rural patients often struggle to find neurologists experienced in complex movement disorder management.
Bookimed Expert Insight: Patient volume data suggests a massive gap between general care and specialized neurology. While University Hospital in Krakow serves 455,000 patients annually, only a fraction of facilities handle complex neuro-rehabilitation. Patients should target multi-department centers in major cities. These hubs offer more diagnostic tools like DaTscans and EEG transition studies which smaller clinics lack.
Patient Consensus: Patients describe the system as a lottery where rural residents face significantly higher travel burdens. Many recommend budgeting for private consultations to bypass long queues and secure timely medication adjustments.
Advanced therapies for Parkinson's in Poland include Deep Brain Stimulation, Magnetic Resonance-guided Focused Ultrasound, and continuous infusion pumps. These device-aided treatments help manage symptoms when oral medications become less effective. Major neurological centres in Krakow and Warsaw provide these surgical and non-surgical interventions for motor fluctuates.
Bookimed Expert Insight: Poland ranks 9th globally for medical requests, reflecting its status as a major European neurosurgery hub. University Hospital in Krakow alone treats 455,000 patients annually across 103 departments. This high volume allows specialists to manage complex programming for Deep Brain Stimulation devices that smaller clinics might see less often.
Patient Consensus: Patients in Poland emphasise that long-term success depends on a clinic's ability to provide ongoing programming and dose adjustments. They suggest undergoing cognitive screening first to ensure suitability for surgical interventions.
Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) is available in Poland as a non-invasive option for Parkinson's disease. This incisionless treatment uses ultrasound beams to destroy precise brain tissue areas. It manages tremors and rigidity without the implants or general anaesthetic required for deep brain stimulation surgery.
Bookimed Expert Insight: Poland ranks 9th globally on Bookimed for medical requests, reflecting a massive infrastructure of 88 clinics. While major centres like University Hospital in Krakow serve 455,000 patients annually, MRgFUS availability remains specialised. Patients should confirm if a clinic has the integrated MRI suite required for this specific technology before travelling.
Patient Consensus: Patients note that MRgFUS offers immediate tremor relief but highlight that it is physically intense. Many choose it specifically to avoid implanted hardware, though they emphasise the need for a local neurologist handover once back in Australia.
Private surgery for Parkinson’s disease in Poland is typically scheduled within 1 to 2 weeks. This timeframe covers the period from the initial consultation to the procedure. Private clinics operate efficiently. They avoid the long public system queues that can exceed 12 months for complex neurological care.
Bookimed Expert Insight: Poland carries a high global rank for medical requests. Large centres like the University Hospital in Krakow manage massive patient volumes. This scale allows them to maintain specialised Parkinson’s teams. These teams often bundle diagnostics and surgery into one week for international visitors. This efficiency minimises travel costs for Australians without compromising care standards.
Patient Consensus: Patients find the process moves fast once all medical records are submitted. It is vital to have scans and neurology letters ready in advance. Preparing documents early prevents delays during the final review stage in Poland.
Warsaw, Kraków, Katowice, and Rzeszów serve as the primary hubs for Parkinson's care in Poland. These cities host academic hospitals providing Deep Brain Stimulation (DBS) and device-aided drug infusions. Professional centres include the University Hospital in Krakow and specialized rehabilitation facilities in Rzeszów.
Bookimed Expert Insight: Poland's Parkinson’s care is heavily centralised in major university cities rather than regional towns. The University Hospital in Krakow alone operates 103 departments. This concentration ensures specialists see thousands of movement disorder cases. Highly experienced neurological teams often manage multiple complex treatment paths under one roof.
Patient Consensus: Patients find that major cities like Warsaw and Kraków offer the best access to specialists. They note that travel logistics are important because follow-up care usually requires visiting these academic centres. In Poland, people recommend verifying if a clinic has a dedicated movement-disorder unit for better results.